MetLife Investment Management’s Synchronoss Technologies SNCR Stock Holding History

MetLife Investment Management’s Portfolio SNCR Stock Details SNCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,996	Closed	-$54.8K	–	2347
2020 Q1	$54.8K	Buy	+1,996	New	+$87.9K	﹤0.01%	2224
2019 Q4	–	Sell	-2,029	Closed	-$98.6K	–	2324
2019 Q3	$98.6K	Hold	2,029	–	–	﹤0.01%	2307
2019 Q2	$144K	Buy	+2,029	New	+$114K	﹤0.01%	2207
2018 Q2	–	Sell	-2,203	Closed	-$209K	–	2219
2018 Q1	$209K	Hold	2,203	–	–	﹤0.01%	1863
2017 Q4	$177K	Buy	+2,203	New	+$213K	﹤0.01%	1993

Other funds holding SNCR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

MetLife Investment Management's SNCR Position: Q2 2020 in Review

MetLife Investment Management sold out of Synchronoss Technologies (SNCR) in Q2 2020, closing a stake of 1,996 shares — an estimated $54.8K sold.

MetLife Investment Management first reported a position in SNCR in Q4 2017 and held it in 5 quarters. The position peaked at $209K in Q1 2018. 82 funds tracked by Wall St. Rank hold SNCR as of Q2 2020.

MetLife Investment Management reported no remaining Synchronoss Technologies position as of Q2 2020 after selling out during the quarter.
MetLife Investment Management sold 1,996 Synchronoss Technologies shares in Q2 2020, an estimated $54.8K.
MetLife Investment Management first reported a position in Synchronoss Technologies in Q4 2017 and held it in 5 quarters.
MetLife Investment Management's Synchronoss Technologies position peaked at $209K in Q1 2018.
82 funds tracked by Wall St. Rank held Synchronoss Technologies as of Q2 2020.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.